1. Home
  2. BNED vs MREO Comparison

BNED vs MREO Comparison

Compare BNED & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNED
  • MREO
  • Stock Information
  • Founded
  • BNED 1965
  • MREO 2015
  • Country
  • BNED United States
  • MREO United Kingdom
  • Employees
  • BNED N/A
  • MREO N/A
  • Industry
  • BNED Other Specialty Stores
  • MREO Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNED Consumer Discretionary
  • MREO Health Care
  • Exchange
  • BNED Nasdaq
  • MREO Nasdaq
  • Market Cap
  • BNED 371.2M
  • MREO 424.5M
  • IPO Year
  • BNED N/A
  • MREO N/A
  • Fundamental
  • Price
  • BNED $12.03
  • MREO $2.15
  • Analyst Decision
  • BNED Hold
  • MREO Strong Buy
  • Analyst Count
  • BNED 1
  • MREO 7
  • Target Price
  • BNED N/A
  • MREO $7.71
  • AVG Volume (30 Days)
  • BNED 365.7K
  • MREO 943.2K
  • Earning Date
  • BNED 06-30-2025
  • MREO 05-13-2025
  • Dividend Yield
  • BNED N/A
  • MREO N/A
  • EPS Growth
  • BNED N/A
  • MREO N/A
  • EPS
  • BNED N/A
  • MREO N/A
  • Revenue
  • BNED $1,567,800,000.00
  • MREO N/A
  • Revenue This Year
  • BNED $2.74
  • MREO N/A
  • Revenue Next Year
  • BNED N/A
  • MREO $54.91
  • P/E Ratio
  • BNED N/A
  • MREO N/A
  • Revenue Growth
  • BNED N/A
  • MREO N/A
  • 52 Week Low
  • BNED $6.05
  • MREO $1.58
  • 52 Week High
  • BNED $81.28
  • MREO $5.02
  • Technical
  • Relative Strength Index (RSI)
  • BNED 70.50
  • MREO 40.94
  • Support Level
  • BNED $10.33
  • MREO $2.12
  • Resistance Level
  • BNED $11.25
  • MREO $2.27
  • Average True Range (ATR)
  • BNED 0.49
  • MREO 0.13
  • MACD
  • BNED 0.10
  • MREO -0.02
  • Stochastic Oscillator
  • BNED 92.90
  • MREO 9.09

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: